• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Clough Global Opportunities

Clough Global Opportunities

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Why health insurers won't cover this $300,000-a-year rare disease drug

    Why health insurers won't cover this $300,000-a-year rare disease drug

  2. UPDATE: Why health insurers won't cover this $300,000-a-year rare disease drug

    UPDATE: Why health insurers won't cover this $300,000-a-year rare disease drug

  3. Is Destructive Return of Capital as Bad as It Sounds?

    For closed-end funds, the answer depends on the premium or discount.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.